Cargando…
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that lo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294562/ https://www.ncbi.nlm.nih.gov/pubmed/28169360 http://dx.doi.org/10.1038/srep42125 |
_version_ | 1782505264187965440 |
---|---|
author | Liu, Jie Li, Juan Li, Pingping Wang, Yaochun Liang, Zheyong Jiang, Yina Li, Jing Feng, Chen Wang, Ruiqi Chen, He Zhou, Can Zhang, Jianmin Yang, Jin Liu, Peijun |
author_facet | Liu, Jie Li, Juan Li, Pingping Wang, Yaochun Liang, Zheyong Jiang, Yina Li, Jing Feng, Chen Wang, Ruiqi Chen, He Zhou, Can Zhang, Jianmin Yang, Jin Liu, Peijun |
author_sort | Liu, Jie |
collection | PubMed |
description | Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that loss of DLG5 promoted breast cancer cell proliferation by inhibiting the Hippo signaling pathway and increasing nuclear YAP expression. Furthermore, depletion of DLG5 induced epithelial-mesenchymal transition (EMT) and disrupted epithelial cell polarity, which was associated with altered expression of Scribble, ZO1, E-cadherin and N-cadherin and their mislocalization. Interestingly, we first reported that loss of DLG5 inhibited the interaction of Mst1 and Lats1 with Scribble, which was crucial for YAP activation and the transcription of TEA domain (TEAD) family members. In summary, loss of DLG5 expression promoted breast cancer malignancy by inactivating the Hippo signaling pathway and increasing nuclear YAP. |
format | Online Article Text |
id | pubmed-5294562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52945622017-02-10 Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway Liu, Jie Li, Juan Li, Pingping Wang, Yaochun Liang, Zheyong Jiang, Yina Li, Jing Feng, Chen Wang, Ruiqi Chen, He Zhou, Can Zhang, Jianmin Yang, Jin Liu, Peijun Sci Rep Article Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that loss of DLG5 promoted breast cancer cell proliferation by inhibiting the Hippo signaling pathway and increasing nuclear YAP expression. Furthermore, depletion of DLG5 induced epithelial-mesenchymal transition (EMT) and disrupted epithelial cell polarity, which was associated with altered expression of Scribble, ZO1, E-cadherin and N-cadherin and their mislocalization. Interestingly, we first reported that loss of DLG5 inhibited the interaction of Mst1 and Lats1 with Scribble, which was crucial for YAP activation and the transcription of TEA domain (TEAD) family members. In summary, loss of DLG5 expression promoted breast cancer malignancy by inactivating the Hippo signaling pathway and increasing nuclear YAP. Nature Publishing Group 2017-02-07 /pmc/articles/PMC5294562/ /pubmed/28169360 http://dx.doi.org/10.1038/srep42125 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Liu, Jie Li, Juan Li, Pingping Wang, Yaochun Liang, Zheyong Jiang, Yina Li, Jing Feng, Chen Wang, Ruiqi Chen, He Zhou, Can Zhang, Jianmin Yang, Jin Liu, Peijun Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway |
title | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway |
title_full | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway |
title_fullStr | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway |
title_full_unstemmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway |
title_short | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway |
title_sort | loss of dlg5 promotes breast cancer malignancy by inhibiting the hippo signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294562/ https://www.ncbi.nlm.nih.gov/pubmed/28169360 http://dx.doi.org/10.1038/srep42125 |
work_keys_str_mv | AT liujie lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT lijuan lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT lipingping lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT wangyaochun lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT liangzheyong lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT jiangyina lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT lijing lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT fengchen lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT wangruiqi lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT chenhe lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT zhoucan lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT zhangjianmin lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT yangjin lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway AT liupeijun lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway |